(Q79366369)

English

Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration

scientific article published on 18 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111146%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111146%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

based on heuristic

inferred from title

macular degeneration

1 reference

based on heuristic

inferred from title

author name string

Ratimir Lazic

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111146%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Nikica Gabric

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111146%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

18 November 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111146%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Graefe's Archive for Clinical and Experimental Ophthalmology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111146%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

245

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111146%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111146%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

68-73

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111146%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

https://scigraph.springernature.com/pub.10.1007/s00417-006-0466-4

0 references

Effects of bevacizumab on retinal function in isolated vertebrate retina

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overview of bevacizumab: a new cancer therapeutic strategy targeting vascular endothelial growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural history of occult choroidal neovascularisation associated with age-related macular degeneration. A systematic review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor: basic science and clinical progress

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Introduction to the topic: Off-label use of bevacizumab in the treatment of neovascular age-related macular degeneration]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of vascular endothelial growth factor in ocular health and disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Bevacizumab for treatment of macular edema secondary to retinal vein occlusion]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitors of ocular neovascularization: promises and potential problems.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab for recurring choroidal neovascularisation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracameral bevacizumab for iris rubeosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologic therapy for colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Intravitreal bevacizumab for neovascular age-related macular degeneration]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal triamcinolone acetonide for exudative age related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Testing intravitreal toxicity of bevacizumab (Avastin).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79366369&oldid=1530157697"